Fig. 2
A. HPV negative conversion rates after Hiporfin-PDT in treating HSIL in the female lower reproductive tract. B. HPV persistent rates after Hiporfin-PDT in treating HSIL in the female lower reproductive tract.
Fig. 2 | Scientific Reports
A. HPV negative conversion rates after Hiporfin-PDT in treating HSIL in the female lower reproductive tract. B. HPV persistent rates after Hiporfin-PDT in treating HSIL in the female lower reproductive tract.
